That made it the largest contributor to Merck's total quarterly sales of $16.1 billion. Ongoing clinical trials and further ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Merck, a leading science and technology company, today announced a € 70 million expansion of its ADC manufacturing ...

Despite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for Q3 by a large margin. See ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced a $76 million expansion of its ADC manufacturing ...

Merck has recently inaugurated its new 290 million-euro biosafety testing facility in Rockville, Maryland, USA with an aim to ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely, as Merck's future hinges on new drug developments amid looming patent expirations. Keytruda is now under ...

Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ...